Flaviviruses are a large group of RNA viruses spread primarily by mosquitoes and ticks, responsible for diseases like dengue, Zika, yellow fever, West Nile, and Japanese encephalitis. They belong to the Flaviviridae family and carry a single strand of positive-sense RNA roughly 11,000 nucleotides long. More than half of the known flaviviruses cause disease in humans, and collectively they infect hundreds of millions of people each year, making them one of the most consequential virus groups on the planet.
How Flaviviruses Spread
Nearly all flaviviruses cycle between biting arthropods and vertebrate hosts. Mosquitoes are the dominant carriers, with two genera doing most of the work. Aedes mosquitoes, recognizable by their black-and-white-striped bodies, transmit dengue, Zika, and yellow fever. These species breed in small pools of standing water: flower pots, discarded tires, tree holes, even bottle caps. Culex mosquitoes, which are brownish-yellow and tend to breed in larger water bodies and stagnant containers, carry West Nile virus, Japanese encephalitis virus, Murray Valley encephalitis virus, and St. Louis encephalitis virus.
Ticks transmit a separate cluster of flaviviruses. Tick-borne encephalitis virus circulates across Europe and northern Asia. Omsk hemorrhagic fever virus is restricted to western Siberia and spread by Dermacentor ticks. Kyasanur Forest disease virus, locally called “monkey fever,” has so far been found only in Karnataka, India. In 1995, a related tick-borne flavivirus called Alkhurma virus was identified in Saudi Arabia after causing severe hemorrhagic illness.
Major Diseases Caused by Flaviviruses
Flavivirus infections range from completely silent to fatal, but they generally fall into two broad patterns: hemorrhagic disease and neurological disease.
Hemorrhagic Flaviviruses
Yellow fever is the original hemorrhagic flavivirus and the one that gave the whole family its name (flavus is Latin for “yellow”). It can cause liver damage, jaundice, and internal bleeding. Dengue is far more widespread. Classical dengue fever brings sudden high fever, severe headache, nausea, and muscle pain. A subset of patients, especially children under 15 and people previously infected with a different dengue strain, develop dengue hemorrhagic fever or dengue shock syndrome. The WHO reported over 7.6 million dengue cases in the first four months of 2024 alone, with more than 16,000 severe cases and over 3,000 deaths across at least 90 countries. Those numbers are almost certainly undercounts because many endemic countries lack strong detection and reporting systems.
Neurotropic Flaviviruses
Japanese encephalitis, West Nile, and tick-borne encephalitis viruses preferentially target the nervous system. They can cause encephalitis (brain inflammation), encephalopathy, transverse myelitis (spinal cord inflammation), and Guillain-Barré syndrome, a condition where the immune system attacks peripheral nerves. Zika virus crosses between categories: it typically causes mild fever and rash, but it can trigger Guillain-Barré syndrome in adults and, in pregnant women, congenital Zika syndrome, which causes severe brain abnormalities in the developing fetus.
Most people infected with any flavivirus never develop symptoms or experience only a brief, mild fever. Severe disease represents the tip of a much larger iceberg of infections.
How the Virus Works Inside Your Cells
A flavivirus particle is small and enveloped in a layer of fat stolen from the host cell it last budded from. Its surface is studded with envelope proteins that latch onto receptors on human cells. Once attached, the virus is pulled inside the cell through a process called clathrin-dependent endocytosis, essentially hijacking the cell’s normal system for importing molecules.
Inside the cell, the virus reaches a compartment called an endosome, where acidity triggers a shape change in the envelope protein. This causes the viral membrane to fuse with the endosome membrane, dumping the RNA genome into the cell’s cytoplasm. That RNA is “positive-sense,” meaning the cell’s own machinery can read it directly like a messenger RNA and immediately start producing viral proteins. The single long RNA strand is translated into one large protein that gets sliced into ten pieces: three structural proteins that form new virus particles and seven nonstructural proteins that copy the viral genome and evade the immune response.
New virus particles assemble in the endoplasmic reticulum, where freshly made RNA and structural proteins come together into immature particles wrapped in a lipid envelope. These particles mature as they travel through the cell’s secretory pathway and are eventually released to infect neighboring cells.
Why Diagnosing the Right Flavivirus Is Difficult
One of the most frustrating features of flaviviruses is how similar they look to the immune system. When your body fights off one flavivirus, it produces antibodies that partially recognize other flaviviruses too. Medically important flaviviruses have been organized into eight groups, called serocomplexes, that trigger overlapping immune responses. Standard blood tests detect these antibodies, but they often can’t distinguish which specific virus caused the current infection.
This problem gets worse in tropical regions where multiple flaviviruses circulate at the same time. Someone living in Southeast Asia may have been exposed to dengue, Japanese encephalitis, and Zika over a lifetime. Each exposure layers more cross-reactive antibodies onto the last, making it extremely difficult to pinpoint which virus is responsible for a new illness. More advanced molecular tests that detect viral genetic material can confirm the specific virus, but these aren’t widely available in many of the places where flaviviruses hit hardest.
Vaccines and Treatment Options
Vaccines exist for four flavivirus diseases. The yellow fever vaccine (YF-Vax) has been in use for decades and provides strong, often lifelong protection with a single dose. Vaccines are also licensed in the United States for Japanese encephalitis (Ixiaro), tick-borne encephalitis (TicoVac), and dengue (Dengvaxia). The dengue vaccine comes with an important caveat: it’s recommended only for people who have already had a confirmed dengue infection, because vaccinating someone with no prior exposure can increase the risk of severe disease upon a first natural infection.
No antiviral drug has been approved to treat any flavivirus infection. Multiple candidates have been tested in clinical trials, including repurposed drugs like chloroquine, ivermectin, and balapiravir, but none has demonstrated clear enough benefit to earn approval. A compound called AT-752, which targets the viral enzyme responsible for copying RNA, is currently in phase 2 trials. For now, treatment remains supportive: managing fever, maintaining hydration, and monitoring for complications.
Preventing Flavivirus Infections
Because most flaviviruses depend on mosquitoes, reducing mosquito populations is the front line of prevention. Traditional methods include eliminating standing water where mosquitoes breed, using insecticide-treated bed nets, and applying repellents containing DEET or picaridin.
A newer biological approach uses Wolbachia, a naturally occurring bacterium found in many insect species but not normally in Aedes aegypti, the primary dengue and Zika mosquito. When male mosquitoes carrying Wolbachia mate with wild females that don’t carry it, the resulting eggs never hatch. Communities in Texas, California, Singapore, Thailand, Mexico, Australia, and Puerto Rico have released Wolbachia-carrying mosquitoes and reported significant drops in Aedes aegypti populations. In the United States, this approach is regulated by the EPA, and releases require an Experimental Use Permit. One limitation: Wolbachia-carrying mosquitoes only suppress Aedes aegypti. Controlling Culex and other mosquito species still requires conventional integrated pest management.
For tick-borne flaviviruses, prevention centers on avoiding tick habitats, wearing protective clothing, using tick repellents, and checking your body for ticks after spending time outdoors in endemic regions of Europe and Asia.